Adjusting Lantus for Hypoglycemia

Immediate Dose Adjustment Algorithm

For any hypoglycemic event, first determine if there is a clear reversible cause, and if no clear reason is identified, reduce the Lantus dose by 10-20% 1, 2
For severe or recurrent nocturnal hypoglycemia, use a 20% reduction, and for mild, isolated hypoglycemia, a 10% reduction may be sufficient 3

Intensify glucose monitoring immediately after any dose adjustment, checking fasting blood glucose daily for at least one week, and for nocturnal hypoglycemia, check blood glucose at bedtime, 3:00 AM, and upon waking for several days 3
Target fasting glucose range of 80-130 mg/dL 1

If more than 50% of fasting glucose values remain above target after one week of the reduced dose, increase by 2 units, and if two or more fasting glucose values per week fall below 80 mg/dL, decrease by an additional 2 units 3
Make adjustments every 3 days during active titration 1

Evaluate for overbasalization, looking for clinical signals including high bedtime-to-morning glucose differential, which suggests excessive basal insulin masking insufficient mealtime coverage 4, 1
Consider changing Lantus administration from evening to morning to reduce nocturnal hypoglycemia risk while maintaining 24-hour coverage 3

Continuing the same dose without adjustment after a hypoglycemic event significantly increases risk of recurrent severe hypoglycemia 2
Not providing glucagon for emergency use, as all patients on basal insulin should have glucagon available 3

Consider switching to newer ultra-long-acting basal analogs, such as insulin degludec or U-300 glargine, which have lower nocturnal hypoglycemia rates than U-100 glargine 4
Evaluate whether the patient has developed hypoglycemia unawareness, which requires more frequent monitoring and potentially less aggressive glycemic targets 2
If basal insulin dose exceeds 0.5-1.0 units/kg/day, consider splitting insulin regimen into separate basal and prandial components rather than continuing to escalate Lantus alone 1

Schedule reassessment within 1-2 weeks after any dose reduction for hypoglycemia to review glucose logs, identify patterns, and make further adjustments as needed 3